{"id":1737,"date":"2018-08-10T21:54:51","date_gmt":"2018-08-10T21:54:51","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=44368"},"modified":"2018-08-10T21:54:51","modified_gmt":"2018-08-10T21:54:51","slug":"nationally-syndicated-today-and-more-feature-medical-marijuana-inc-as-part-of-cbd-coverage","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2018\/08\/10\/nationally-syndicated-today-and-more-feature-medical-marijuana-inc-as-part-of-cbd-coverage\/","title":{"rendered":"Nationally Syndicated Today and More Feature Medical Marijuana, Inc. as Part of CBD Coverage"},"content":{"rendered":"

CBD news, research, and products lead Medical Marijuana, Inc.\u2019s headlines this week in major media outlets.<\/span><\/i><\/h3>\n

CBD continues to become a household term as more and more people are becoming aware of its amazing potential as a daily supplement. Keep reading to get the biggest news stories from the Medical Marijuana, Inc. family of companies. <\/span><\/p>\n

Today Features Products from Medical Marijuana, Inc.<\/span><\/h2>\n

Popular daytime television program <\/span>Today<\/span><\/a> ran a segment this week looking at the booming cannabis industry, including a special look at CBD. Medical Marijuana, Inc.\u2019s Cibaderm CBD-infused shampoo was included in Today\u2019s segment alongside other mainstream CBD products. <\/span><\/p>\n

The segment also included an interview with Dr. Roshini Raj and featured a number of products that contained either CBD, THC, or a combination of both. Dr. Raj discussed the research results that have been published so far about CBD. <\/span><\/p>\n

Kannalife\u2122 Sciences Goes Public with Share Exchange<\/span><\/h2>\n

Kannalife\u2122 Sciences announced this past week that it had merged with TYG Solutions Corp through a share exchange transaction, making it a publicly-traded company.<\/span><\/p>\n

News of this share exchange was picked up by Philadelphia\u2019s <\/span>The Inquirer \u2013 Daily News<\/span><\/a>. According to the article, \u201cThe products the company creates, synthetic cannabinoids including the molecule CBD, are <\/span>used in research at Temple University<\/span><\/a> and other schools for the study of brain injuries, including chronic traumatic encephalopathy (CTE). The company, a spokesman said, does not touch the marijuana plant.\u201d<\/span><\/p>\n

\u201cWhile we certainly don’t consider ourselves an ‘anything cannabis’ company, we haven’t lost sight of the fact that Kannalife was among a select few companies in the pharmaceutical space to approach drug development in cannabinoid therapeutics,\u201d said Kannalife CEO Dean Petkanas. <\/span><\/p>\n

This news was also picked up by the <\/span>Philadelphia Business Journal<\/span><\/a>. <\/span><\/p>\n

Kannalife\u2122 Sciences spokesperson and former NFL star Nick Lowery stopped by the <\/span>Tiki and Tierney<\/span><\/a> show on CBS Sports Radio to talk football and to promote the research being completed by Kannalife\u2122 into the potential to create a synthetic cannabinoid treatment option for CTE, opioid addiction, and other conditions. <\/span><\/p>\n